交易 Humacyte, Inc. - HUMA CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.05 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Mar 28, 2024 | 3.08 | -0.02 | -0.65% | 3.10 | 3.12 | 3.04 |
Mar 27, 2024 | 3.07 | -0.03 | -0.97% | 3.10 | 3.23 | 3.05 |
Mar 26, 2024 | 3.05 | -0.10 | -3.17% | 3.15 | 3.17 | 3.03 |
Mar 25, 2024 | 3.12 | -0.28 | -8.24% | 3.40 | 3.40 | 3.11 |
Mar 22, 2024 | 3.28 | -0.31 | -8.64% | 3.59 | 3.59 | 3.24 |
Mar 21, 2024 | 3.58 | 0.04 | 1.13% | 3.54 | 3.63 | 3.54 |
Mar 20, 2024 | 3.48 | -0.02 | -0.57% | 3.50 | 3.57 | 3.39 |
Mar 19, 2024 | 3.46 | 0.02 | 0.58% | 3.44 | 3.58 | 3.41 |
Mar 18, 2024 | 3.48 | 0.09 | 2.65% | 3.39 | 3.59 | 3.25 |
Mar 15, 2024 | 3.21 | 0.10 | 3.22% | 3.11 | 3.27 | 3.11 |
Mar 14, 2024 | 3.14 | -0.09 | -2.79% | 3.23 | 3.27 | 3.10 |
Mar 13, 2024 | 3.26 | 0.02 | 0.62% | 3.24 | 3.36 | 3.22 |
Mar 12, 2024 | 3.28 | 0.18 | 5.81% | 3.10 | 3.32 | 3.02 |
Mar 11, 2024 | 3.08 | -0.19 | -5.81% | 3.27 | 3.38 | 3.02 |
Mar 8, 2024 | 3.34 | 0.01 | 0.30% | 3.33 | 3.49 | 3.28 |
Mar 7, 2024 | 3.24 | -0.09 | -2.70% | 3.33 | 3.34 | 3.20 |
Mar 6, 2024 | 3.34 | -0.14 | -4.02% | 3.48 | 3.49 | 3.15 |
Mar 5, 2024 | 3.45 | -0.04 | -1.15% | 3.49 | 3.58 | 3.34 |
Mar 4, 2024 | 3.50 | 0.20 | 6.06% | 3.30 | 3.67 | 3.30 |
Mar 1, 2024 | 3.22 | 0.24 | 8.05% | 2.98 | 3.49 | 2.98 |
Humacyte, Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Friday, May 10, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 Q1 2024 Humacyte Inc Earnings Release Q1 2024 Humacyte Inc Earnings ReleaseForecast(預報) -返回 - |
Thursday, June 6, 2024 | ||
時間 (UTC) 12:00 | 國家 US
| 事件 Humacyte Inc Annual Shareholders Meeting Humacyte Inc Annual Shareholders MeetingForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
總收入 | 1.565 | 1.263 | 1.491 | 6.187 |
收入 | 1.565 | 1.263 | 1.491 | 6.187 |
總營業費用 | 86.143 | 79.187 | 66.091 | 91.878 |
銷售/一般/行政費用,總計 | 22.883 | 21.13 | 12.013 | 16.275 |
研究與開發 | 63.26 | 61.341 | 54.078 | 75.603 |
異常費用(收入) | 0 | -3.284 | 0 | 0 |
營業收入 | -84.578 | -77.924 | -64.6 | -85.691 |
利息收入(費用),非經營淨值 | -3.571 | -4.332 | -1.924 | 0.269 |
稅前淨收入 | -11.965 | -26.477 | -66.524 | -85.422 |
稅後淨收入 | -11.965 | -26.477 | -66.524 | -85.422 |
未計算非常項目前的淨收益 | -11.965 | -26.477 | -66.524 | -85.422 |
淨收入 | -11.965 | -26.477 | -66.524 | -85.422 |
普通股股東可獲收益 (不含非經常性項目) | -11.965 | -26.477 | -66.524 | -85.422 |
普通股股東可獲收益 (含非經常性項目) | -11.965 | -26.477 | -66.524 | -85.422 |
攤薄淨收入 | -11.965 | -26.477 | -66.524 | -85.422 |
攤薄後加權平均股 | 103.051 | 103.003 | 103.003 | 103.003 |
扣除特別項目的每股攤薄盈利 | -0.11611 | -0.25705 | -0.64584 | -0.82931 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.11611 | -0.28893 | -0.64584 | -0.82931 |
其他,淨值 | 76.184 | 55.779 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0.031 | 1.301 |
收入 | 0 | 0 | 0 | 0.031 | 1.301 |
總營業費用 | 26.045 | 22.512 | 20.79 | 23.525 | 19.832 |
銷售/一般/行政費用,總計 | 6.191 | 5.234 | 5.833 | 6.188 | 5.18 |
研究與開發 | 20.54 | 17.278 | 14.957 | 17.337 | 14.652 |
營業收入 | -26.045 | -22.512 | -20.79 | -23.494 | -18.531 |
利息收入(費用),非經營淨值 | -0.231 | -0.224 | -0.225 | -0.758 | -1.187 |
其他,淨值 | 3.57 | -14.233 | 17.295 | -1.029 | 56.586 |
稅前淨收入 | -22.706 | -36.969 | -3.72 | -25.281 | 36.868 |
稅後淨收入 | -22.706 | -36.969 | -3.72 | -25.281 | 36.868 |
未計算非常項目前的淨收益 | -22.706 | -36.969 | -3.72 | -25.281 | 36.868 |
淨收入 | -22.706 | -36.969 | -3.72 | -25.281 | 36.868 |
普通股股東可獲收益 (不含非經常性項目) | -22.706 | -36.969 | -3.72 | -25.281 | 36.868 |
普通股股東可獲收益 (含非經常性項目) | -22.706 | -36.969 | -3.72 | -25.281 | 36.868 |
攤薄淨收入 | -22.706 | -36.969 | -3.72 | -25.281 | 36.868 |
攤薄後加權平均股 | 103.362 | 103.264 | 103.163 | 103.032 | 103.908 |
扣除特別項目的每股攤薄盈利 | -0.21968 | -0.35801 | -0.03606 | -0.24537 | 0.35481 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.22631 | -0.35801 | -0.03606 | -0.24537 | 0.35481 |
異常費用(收入) | -0.686 | 0 | 0 | 0 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
流動資産總額 | 154.208 | 229.34 | 41.449 | 94.954 |
現金和短期投資 | 151.879 | 225.502 | 39.929 | 93.713 |
現金等價物 | 149.772 | 217.502 | 39.929 | 93.713 |
應收賬款總額,淨額 | 0.031 | 0.176 | 0.113 | 0.601 |
應收賬款 - 貿易,淨額 | 0.031 | 0.176 | 0.113 | 0.601 |
預付的費用 | 2.298 | 3.662 | 1.407 | 0.64 |
總資産 | 204.302 | 286.533 | 106.688 | 168.691 |
物業/廠房/設備,總計 - 淨額 | 50.094 | 57.193 | 65.239 | 73.737 |
物業/廠房/設備,總計 - 總額 | 76.275 | 77.633 | 79.5 | 82.154 |
累計折舊,總計 | -26.181 | -20.44 | -14.261 | -8.417 |
其他長期資産,總計 | 0 | 0 | ||
流動負債總額 | 19.58 | 11.05 | 11.233 | 10.842 |
應付賬款 | 1.595 | 2.094 | 2.274 | 3.272 |
預提費用 | 7.158 | 6.802 | 4.634 | 6.07 |
應付票據/短期債務 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 10.827 | 1.981 | 4.18 | 1.5 |
其他流動負債,總計 | 0 | 0.173 | 0.145 | 0 |
負債總額 | 87.374 | 164.359 | 36.016 | 36.49 |
長期債務總額 | 39.189 | 48.47 | 23.912 | 24.819 |
長期債務 | 20.336 | 27.361 | 0.822 | 0 |
資本租賃義務 | 18.853 | 21.109 | 23.09 | 24.819 |
遞延所得稅 | 0 | 0.144 | 0 | |
其他負債,總計 | 28.605 | 104.839 | 0.727 | 0.829 |
股權 | 116.928 | 122.174 | 70.672 | 132.201 |
Redeemable Preferred Stock | 420.989 | 420.989 | ||
普通股 | 0.01 | 0.01 | 0.022 | 0.021 |
額外實收資本 | 543.456 | 536.737 | 37.757 | 32.763 |
留存收益(累計赤字) | -426.538 | -414.573 | -388.096 | -321.572 |
總負債和股東權益 | 204.302 | 286.533 | 106.688 | 168.691 |
已發行普通股總數 | 103.229 | 103.004 | 103.003 | 103.003 |
短期投資 | 2.107 | 8 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 102.851 | 120.562 | 133.855 | 154.208 | 174.612 |
現金和短期投資 | 99.986 | 114.604 | 131.677 | 151.879 | 171.731 |
現金等價物 | 99.986 | 114.604 | 129.57 | 149.772 | 163.731 |
應收賬款總額,淨額 | 0 | 0 | 0 | 0.031 | 0.031 |
應收賬款 - 貿易,淨額 | 0 | 0 | 0 | 0.031 | 0.031 |
預付的費用 | 2.721 | 5.958 | 2.178 | 2.298 | 2.85 |
總資産 | 149.385 | 168.106 | 182.976 | 204.302 | 226.219 |
物業/廠房/設備,總計 - 淨額 | 45.679 | 47.544 | 49.121 | 50.094 | 51.607 |
物業/廠房/設備,總計 - 總額 | 75.927 | 76.477 | 76.86 | 76.275 | 76.599 |
累計折舊,總計 | -30.248 | -28.933 | -27.739 | -26.181 | -24.992 |
其他長期資産,總計 | 0.855 | ||||
流動負債總額 | 15.137 | 11.388 | 23.601 | 19.58 | 17.906 |
應付賬款 | 3.018 | 2.362 | 1.954 | 1.595 | 3.255 |
預提費用 | 9.638 | 6.622 | 6.461 | 7.158 | 8.007 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 2.481 | 2.404 | 15.186 | 10.827 | 6.471 |
其他流動負債,總計 | 0 | 0.173 | |||
負債總額 | 112.392 | 106.989 | 101.089 | 87.374 | 107.547 |
長期債務總額 | 16.96 | 17.614 | 34.662 | 39.189 | 43.728 |
長期債務 | 0 | 0 | 16.41 | 20.336 | 24.286 |
資本租賃義務 | 16.96 | 17.614 | 18.252 | 18.853 | 19.442 |
遞延所得稅 | |||||
其他負債,總計 | 80.295 | 77.987 | 42.826 | 28.605 | 45.913 |
股權 | 36.993 | 61.117 | 81.887 | 116.928 | 118.672 |
Redeemable Preferred Stock | |||||
普通股 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
額外實收資本 | 549.191 | 547.32 | 545.384 | 543.456 | 541.48 |
留存收益(累計赤字) | -512.208 | -486.213 | -463.507 | -426.538 | -422.818 |
總負債和股東權益 | 149.385 | 168.106 | 182.976 | 204.302 | 226.219 |
已發行普通股總數 | 103.461 | 103.408 | 103.329 | 103.229 | 103.099 |
短期投資 | 0 | 0 | 2.107 | 2.107 | 8 |
其他流動資産,總計 | 0.144 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
淨收入/起跑線 | -11.965 | -26.477 | -66.524 | -85.422 |
經營活動産生的現金 | -71.129 | -81.19 | -55.568 | -71.787 |
經營活動産生的現金 | 8.21 | 8.241 | 8.351 | 6.749 |
非現金物品 | -68.403 | -62.397 | 4.974 | 4.588 |
已付現金利息 | 2.668 | 1.123 | 0 | 0 |
營運資金的變化 | 1.029 | -0.557 | -2.369 | 2.298 |
投資活動産生的現金 | 4.845 | -8.22 | -0.268 | -8.125 |
資本支出 | -1.048 | -0.22 | -0.318 | -8.125 |
其他投資現金流量項目,總計 | 5.893 | -8 | 0.05 | 0 |
融資活動産生的現金 | -1.446 | 266.983 | 2.052 | -0.074 |
融資現金流項目 | 0 | -3.945 | 0 | 0 |
股票的發行(報廢),淨額 | 0.535 | 0.598 | 0.301 | 1.218 |
債務的發行(退還),淨額 | -1.981 | 270.33 | 1.751 | -1.292 |
現金淨變化 | -67.73 | 177.573 | -53.784 | -79.986 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -36.969 | -11.965 | -8.245 | 17.036 | -19.832 |
Cash From Operating Activities | -18.641 | -71.129 | -52.17 | -35.366 | -18.797 |
Cash From Operating Activities | 2.073 | 8.21 | 6.096 | 4.061 | 2.04 |
Non-Cash Items | 16.414 | -68.403 | -53.13 | -56.087 | -1.396 |
Cash Interest Paid | 0.881 | 2.668 | 1.867 | 1.165 | 0.563 |
Changes in Working Capital | -0.159 | 1.029 | 3.109 | -0.376 | 0.391 |
Cash From Investing Activities | -1.152 | 4.845 | -0.367 | -0.156 | -0.022 |
Capital Expenditures | -1.152 | -1.048 | -0.367 | -0.156 | -0.022 |
Cash From Financing Activities | -0.409 | -1.446 | -1.234 | -0.945 | -0.461 |
Financing Cash Flow Items | 0 | 0 | 0 | 0 | |
Issuance (Retirement) of Stock, Net | 0.119 | 0.535 | 0.229 | 0.012 | 0.001 |
Issuance (Retirement) of Debt, Net | -0.528 | -1.981 | -1.463 | -0.957 | -0.462 |
Net Change in Cash | -20.202 | -67.73 | -53.771 | -36.467 | -19.28 |
Other Investing Cash Flow Items, Total | 5.893 | 0 | 0 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Biotechnology & Medical Research (NEC) |
2525 East North Carolina Highway 54
DURHAM
NORTH CAROLINA 27713
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 580.000 多名交易者,選擇與 Capital.com 交易